keyboard_arrow_up

Three Important Questions to Ask at Your First Prenatal Appointment

ROSEMONT, PA, January 13, 2014 – From morning sickness to stretch marks, when you find out you’re pregnant, you’ll likely have a long list of questions about the changes you experience in the first trimester and throughout pregnancy. Your first prenatal visit usually occurs around the 8th week of pregnancy, and you can make good use of that time to prepare for your first appointment.

What should you know before you meet with your healthcare professional? To help you get started, check out the latest video in Duchesnay USA’s Navigating Morning Sickness series as Dr. Joanne L. Stone, Maternal & Fetal Medicine Division Director at the Mount Sinai School of Medicine, shares three key questions you might want to ask your healthcare professional. Plus, learn about early signs of pregnancy that are important to track and discuss during your first prenatal visit – these include bloating, food aversions, dizziness, fatigue, or morning sickness.

The Navigating Morning Sickness video series is part of a national morning sickness education initiative, including social media (@NVPregnancy) and resources on www.MorningSicknessUSA.com. Pregnant women, their friends and families can view the Navigating Morning Sickness videos on YouTube and www.MorningSicknessUSA.com/KnowledgeCenter/Videos.

About Nausea and Vomiting of Pregnancy (NVP)

Nausea and vomiting of pregnancy (NVP), or morning sickness, affects 70 to 85 percent of pregnant women. NVP can present differently for each woman, the symptoms include: nausea, gagging, retching, dry heaving, vomiting, and odor and/or food aversion. For most pregnant women, symptoms generally end at approximately 16 to 20 weeks. However, some women can experience symptoms throughout their pregnancy. For more information please visit www.MorningSicknessUSA.com or follow on Twitter.

About Duchesnay USA

Duchesnay USA is a unique healthcare company devoted to safeguarding the health and well-being of expectant mothers and their unborn babies. Its affiliate company, Duchesnay Inc. was founded in 1970 in Canada, the family-owned company realigned its business in 1992 to focus specifically on pregnant women after a family member experienced a very difficult pregnancy. Duchesnay USA was established in Rosemont, Pennsylvania in 2011 to pursue that same mission. Realizing a lack of sufficient information on medications for use in pregnancy, Duchesnay USA strives to ensure that expectant women who require pharmacological treatments have access to medical advice and therapies that are safe for them and their unborn babies. Duchesnay USA’s mission is to develop pharmacological solutions to reduce the symptoms of nausea and vomiting during pregnancy (NVP). For more information on Duchesnay USA, please visit www.DuchesnayUSA.com.

References

Dr. Joanne Stone is a paid spokesperson of Duchesnay USA

Jewell, D, Young, G. Interventions for Nausea and Vomiting in Early Pregnancy. The Cochrane Library. 2002; 1.

Medalie, J. Relationship between Nausea and Vomiting in Early Pregnancy and/or Abortion. The Lancet. 1957; 117-119.

Whitehead, SA, Andrews, LR, Chamberlain, VP. Characterisation of Nausea and Vomiting in Early Pregnancy: A Survey of 1000 Women. Journal of Obstetrics and Gynaecology. 1992; 12: 384-369.

Gadsby, R, Barnie-Adshead, A, Jagger, C. A Prospective Study of Nausea and Vomiting During Pregnancy. British Journal of General Practice. 1993; 43: 245-248.

Clark S, Costantine M, Hankins GDV. Review of NVP and HG and early pharmacotherapeutic Intervention. Obstetrics and Gynecology International Volume. 2012. 

Jarnfelt-Samsioe, A, Samsio, G, Velinder, G. Nausea and Vomiting in Pregnancy – A Contribution to Its Epidemiology.  Gynecologic and Obstetric Investigation. 1983; 16: 221-229.